Caro JJ - Search Results

1

Pharmacoeconomic analyses using discrete event simulation.

Caro JJ. Caro JJ. Pharmacoeconomics. 2005;23(4):323-32. doi: 10.2165/00019053-200523040-00003. Pharmacoeconomics. 2005. PMID: 15853433

2

Pharmacoeconomic evidence and considerations for triptan treatment of migraine.

Caro JJ, Getsios D. Caro JJ, et al. Expert Opin Pharmacother. 2002 Mar;3(3):237-48. doi: 10.1517/14656566.3.3.237. Expert Opin Pharmacother. 2002. PMID: 11866674 Review.

3

Lifetime costs of complications resulting from type 2 diabetes in the U.S.

Caro JJ, Ward AJ, O'Brien JA. Caro JJ, et al. Diabetes Care. 2002 Mar;25(3):476-81. doi: 10.2337/diacare.25.3.476. Diabetes Care. 2002. PMID: 11874933

4

Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

Caro JJ, Getsios D, Caro I, O'Brien JA. Caro JJ, et al. Among authors: caro i. Pharmacoeconomics. 2002;20(9):593-602. doi: 10.2165/00019053-200220090-00003. Pharmacoeconomics. 2002. PMID: 12141887

5

Direct medical cost of managing deep vein thrombosis according to the occurrence of complications.

O'Brien JA, Caro JJ. O'Brien JA, et al. Among authors: caro jj. Pharmacoeconomics. 2002;20(9):603-15. doi: 10.2165/00019053-200220090-00004. Pharmacoeconomics. 2002. PMID: 12141888

6

Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden.

Garfield FB, Getsios D, Caro JJ, Wimo A, Winblad B. Garfield FB, et al. Among authors: caro jj. Pharmacoeconomics. 2002;20(9):629-37. doi: 10.2165/00019053-200220090-00006. Pharmacoeconomics. 2002. PMID: 12141890

7

Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands.

Caro JJ, Salas M, Ward A, Getsios D, Mehnert A; AHEAD Study Group. Assessment of Health Economics in Alzheimer's Disease. Caro JJ, et al. Dement Geriatr Cogn Disord. 2002;14(2):84-9. doi: 10.1159/000064929. Dement Geriatr Cogn Disord. 2002. PMID: 12145455

8

Instituting a routine varicella vaccination program in Canada: an economic evaluation.

Getsios D, Caro JJ, Caro G, De Wals P, Law BJ, Robert Y, Lance JM. Getsios D, et al. Among authors: caro jj, caro g. Pediatr Infect Dis J. 2002 Jun;21(6):542-7. doi: 10.1097/00006454-200206000-00012. Pediatr Infect Dis J. 2002. PMID: 12182379

9

Long term cost-of-illness in stroke: an international review.

Payne KA, Huybrechts KF, Caro JJ, Craig Green TJ, Klittich WS. Payne KA, et al. Among authors: caro jj. Pharmacoeconomics. 2002;20(12):813-25. doi: 10.2165/00019053-200220120-00002. Pharmacoeconomics. 2002. PMID: 12236803 Review.

10

Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus.

Salas M, Ward A, Caro J. Salas M, et al. Clin Ther. 2002 Oct;24(10):1690-705. doi: 10.1016/s0149-2918(02)80072-8. Clin Ther. 2002. PMID: 12462297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results